Siri Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.80 M
as on 08-12-2024
- Paid Up Capital ₹ 2.80 M
as on 08-12-2024
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.90 Cr
as on 08-12-2024
- Satisfied Charges ₹ 2.05 Cr
as on 08-12-2024
- Revenue 44.91%
(FY 2022)
- Profit 7.41%
(FY 2022)
- Ebitda 85.51%
(FY 2022)
- Net Worth 4.74%
(FY 2022)
- Total Assets -4.26%
(FY 2022)
About Siri Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.80 M and a paid-up capital of Rs 2.80 M.
The company currently has active open charges totaling ₹1.90 Cr. The company has closed loans amounting to ₹2.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hanumaiah Kurra and Kurra Kumari serve as directors at the Company.
- CIN/LLPIN
U24116TG1995PTC021369
- Company No.
021369
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Siri Chemicals Private Limited offer?
Siri Chemicals Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Sulfur Fertilizers, Dyes & Color Additives, White Pigments, Chemical Reagents & Catalysts, Inorganic Salts.
Who are the key members and board of directors at Siri Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hanumaiah Kurra  | Director | 09-Aug-1995 | Current |
| Kurra Kumari | Director | 09-Aug-1995 | Current |
Financial Performance of Siri Chemicals.
Siri Chemicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.91% increase. The company also saw a slight improvement in profitability, with a 7.41% increase in profit. The company's net worth moved up by a moderate rise of 4.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siri Chemicals?
In 2019, Siri Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 08 Mar 2021 | ₹3.00 M | Open |
Syndicate Bank Creation Date: 12 Feb 2011 | ₹0.99 M | Open |
Syndicate Bank Creation Date: 05 Mar 2007 | ₹1.50 Cr | Open |
How Many Employees Work at Siri Chemicals?
Unlock and access historical data on people associated with Siri Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siri Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siri Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
